Sinocare Dettes/EBITDA

Que fait Sinocare ? Sinocare, Inc. generates revenue through the development, production, and sale of chronic disease rapid detection products, primarily focusing on blood sugar monitoring systems. The company offers blood sugar testing instruments, related strips, blood sugar testing systems, and mobile blood sugar instruments under its SANNUO brand. These products are sold domestically and internationally, targeting healthcare providers and consumers managing diabetes. Sinocare also provides diabetes management information systems as part of its product portfolio. The SANNUO brand is central to Sinocare's sales strategy, with products distributed across domestic and overseas markets. The company's offerings include micro blood instant blood sugar monitoring systems, which are designed for chronic disease management. Sinocare's revenue streams are derived from direct sales of these medical devices and associated information systems to end-users and healthcare institutions. Sinocare's business model relies on the consistent demand for diabetes management solutions, with its SANNUO-branded products serving both individual consumers and healthcare facilities. The company's product range includes blood sugar testing instruments, strips, and mobile blood sugar instruments, all marketed under the SANNUO label. These products are distributed globally, supporting Sinocare's revenue generation through direct sales channels. Sinocare est l'une des entreprises les plus populaires sur Eulerpool.